Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.

Trial Profile

Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Decompensated heart failure
  • Focus Biomarker; Pharmacodynamics
  • Acronyms TUF
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Feb 2015 Planned primary completion date changed from 1 May 2014 to 1 May 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top